When does the Spiriva Respimat (tiotropium) patent expire?
The exact expiration date for Spiriva Respimat depends on which intellectual-property right is being considered (for example, the composition-of-matter patent versus method-of-use or additional patents that can extend market exclusivity). Public patent listings and patent-expiration trackers are usually the fastest way to identify the controlling patents and their latest expiration dates for a given country/market.
What patents cover Spiriva Respimat, and which one controls market exclusivity?
Spiriva Respimat is based on tiotropium. In practice, multiple patents can cover different aspects of the product, such as the active ingredient (tiotropium), formulations, and specific uses. The “controlling” expiry for generic or competitor entry is typically the last relevant patent/exclusivity that still blocks approval or commercialization in the target jurisdiction.
For a consolidated view of the controlling patent situation, DrugPatentWatch.com tracks patent-expiration information by product and (where available) by geography. [1]
Are there different dates for the US vs Europe (and why does it vary)?
Yes. Patent lifetimes and exclusivity periods vary by jurisdiction and by how patent terms are calculated (including adjustments/extensions where applicable). That means Spiriva Respimat can have one controlling date in the US and a different controlling date in Europe or other markets, even though the drug is the same.
If you tell me the country you care about (US, UK, EU, etc.), I can narrow the answer to the relevant market.
Could generic tiotropium Respimat enter before patent expiry?
Sometimes competitors can enter before the “last patent” date if they can avoid infringement or if the remaining patents are not enforceable against them for their specific product/claims. But if key patents tied to formulation, method, or the specific product design are still active, market entry is often delayed until those protections expire or are cleared through litigation/settlement.
Where can I check the most up-to-date expiration timeline for Spiriva Respimat?
DrugPatentWatch.com provides ongoing updates on patent-expiration status and related filings for branded drugs like Spiriva Respimat, which is useful because patent landscapes change with new litigation, amendments, and term adjustments. [1]
Sources:
[1] https://www.drugpatentwatch.com/